본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

Genomics & informatics v.5 no.4, 2007년, pp.161 - 167  
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Genetic Polymorphisms of UGT1A and their Association with Clinical Factors in Healthy Koreans

Kim, Jeong-Oh   (Laboratory of Medical Oncology, Catholic Research Institutes of Medical Science, The Catholic University of KoreaUU0013933  ); Shin, Jeong-Young   (Laboratory of Medical Oncology, Catholic Research Institutes of Medical Science, The Catholic University of KoreaUU0013933  ); Lee, Myung-Ah   (Medical Oncology, Kangnam St. Mary's HospitalHH0000225  ); Chae, Hyun-Suk   (Gastroenterology, Uijeongbu St. Mary's Hospital  ); Lee, Chul-Ho   (Department of Clinical Genetics, School of Medicine, Yonsei UniversityUU0000936  ); Roh, Jae-Sook   (KFDA, NITR, Team of Clinical Pharmacology  ); Jin, Sun-Kyung   (KFDA, NITR, Team of Clinical Pharmacology  ); Kang, Tae-Sun   (KFDA, NITR, Team of Clinical Pharmacology  ); Choi, Jung-Ran   (Laboratory of Medical Oncology, Catholic Research Institutes of Medical Science, The Catholic University of KoreaUU0013933  ); Kang, Jin-Hyoung   (Laboratory of Medical Oncology, Catholic Research Institutes of Medical Science, The Catholic University of KoreaUU0013933  );
  • 초록

    Glucuronidation by the uridine diphosphateglucuronosy-ltransferase 1A enzymes (UGT1As) is a major pathway for elimination of particular drugs and endogenous substances, such as bilirubin. We examined the relation of eight single nucleotide polymorphisms (SNPs) and haplotypes of the UGT1A gene with their clinical factors. For association analysis, we genotyped the variants by direct sequencing analysis and polymerase chain reaction (PCR) in 218 healthy Koreans. The frequency of UGT1A1 polymorphisms, -3279T>G, -3156G>A, -53 $(TA)_{6>7}$ , 211G>A, and 686C>A, was 0.26, 0.12, 0.08, 0.15, and 0.01, respectively. The frequency of -118 $(T)_{9>10}$ of UGT1A9 was 0.62, which was significantly higher than that in Caucasians (0.39). Neither the -2152C>T nor the -275T>A polymorphism was observed in Koreans or other Asians in comparison with Caucasians. The -3156G>A and -53 $(TA)_{6>7}$ polymorphisms of UGT1A were significantly associated with platelet count and total bilirubin level (p=0.01, p=0.01, respectively). Additionally, total bilirubin level was positively correlated with occurrence of the UGT1A9-118 $(T)_{9>10}$ rare variant. Common haplotypes encompassing six UGT1A polymorphisms were significantly associated with total bilirubin level (p=0.01). Taken together, we suggest that determination of the UGT1A1 and UGT1A9 genotypes is clinically useful for predicting the efficacy and serious toxicities of particular drugs requiring glucuronidation.


  • 주제어

    Uridine diphosphate glucuronosyltransferases (UGT) .   single nucleotide polymorphism (SNP) .   haplotype .   total bilirubin .   glucuronidation.  

  • 참고문헌 (17)

    1. Kiang, T.K., Ensom, M.H., and Chang, T.K. (2005). UDPglucuronosyltransferases and clinical drug-drug interactions. Pharmacol. Ther. 106, 97-132 
    2. Villeneuve, L., Girard, H., Fortier, L.C., Gagne, J.F., and Guillemette, C. (2003). Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J. Pharmacol. Exp. Ther. 307, 117-128 
    3. Nowell, S.A., Leakey, J.E., Warren, J.F., Lang, N.P., and Frame, L.T. (1998). Identification of enzymes responsible for the metabolism of heme in human platelets. J. Bio. Chem. 273, 33342-33346 
    4. Innocenti, F., Liu, W., Chen, P., Desai, A.A., Das, S. and Ratain, M.J. (2005). Haplotype of variants in the UDPglucuronosyltransferase1A9 and 1A1 genes. Pharmacogenet. Genomics. 15, 295-301 
    5. Jada, S.R., Lim, R., Wong, C.I., Shu, X., Lee, S.C., Zhou, Q., Goh, B.C., and Chowbay, B. (2007). Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci. 98, 1461-1467 
    6. Ahn, C. (2007). Pharmacogenomics in Drug Discovery and Development. Genomics & Informatics. 5(2), 41-45     
    7. Rhu , H.J., Jung, H.Y., Park, J.S., Kim, J.W., Kim, H.T., Park, C.S., Han, B.G., Koh, I.S., Park, C., Kim, K.h., Oh, B.S., and Lee, J.K. (2005). Genetic variants of IL-3 and IL-4 in the Korean population: Polymorphisms, Haplotypes and Linkage Disequilibrium. Genomics & Informatics. 3(4), 149-153     
    8. Iyer, L., Hall, D., Das, S., Mortell, M.A., Ramirez, J., Kim, S., Di Rienzo, A., and Ratain, M.J. (1999). Phenotypegenotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin. Pharmacol. Ther. 65, 576-582 
    9. Minami, H., Sai, K., Saeki, M., Saito, Y., Ozawa, S., Suzuki, K., Kaniwa, N., Sawada, JI., Hamaguchi, T., Yamamoto, N., Shirao, K., Yamada, Y., Ohmatsu, H., Kubota, K., Yoshida, T., Ohtsu, A., and Saijo, N. (2007). Irinotecan pharmacokinetics/pharmacodynamics and UGT1A genetic polymorphisms in Japanese: roles of UGT1A1*6 and *28. Pharmacogenetics and Genomics. 17, 497-504. 
    10. Ando, Y., Saka, H., Ando, M., Sawa, T., Muro, K., Ueoka, H., Yokoyama, A., Saitoh, S., Shimokata, K., and Hasegawa, Y. (2000). Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 60, 6921-6926 
    11. Yamanaka, H., Nakajima, M., Katoh, M., Hara, Y., Tachibana, O., Yamashita, J., McLeod, H.L., and Yokoi, T. (2004). A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics. 14, 329-32 
    12. Riedy, M., Wang, J.Y., and Miller, A.P. (2000). Genomic organization of the UGT2b gene cluster on human chromosome 4q13. Pharmacogenetics. 10, 251-260 
    13. Sandanaraj, E., Jada, S.R., Shu, X., Lim, R., Lee, S.C., Zhou, Q., Zhou, S., Goh, B.D., and Chowbay, B. (2007). Influence of UGT1A9 intronic 1399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients. Pharmacogenomics J. 1-12 
    14. Han, J.Y., Lim, H.S., Shin, E.S., Yoo, Y.K., Park, Y.H., Lee, J.E., Jang, I.J., Lee, D.H., and Lee, J.S. (2006). Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J. Clin. Oncol. 24, 2237-2244 
    15. Marsh, S., and McLeod, H.L. (2004). Pharmacogenetics of irinotecan toxicity. Pharmacogenetics. 5, 835-843 
    16. Innocenti, F., Grimsley, C., Das, S., Ramirez, J., Cheng, C., Kuttab-Boulos, H., Ratain, M.J., and Di Rienzo, A. (2002). Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups. Pharmacogenetics. 12, 725-733 
    17. Mackenzie, P.I., Owens, I.S., Burchell, B., Bock, K.W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D.W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J.R., Ritter, J.K., Schachter, H., Tephly, T.R., Tipton, K.F., and Nebert, D.W. (1997). The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7, 255-269 

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • NDSL :
  • 한국유전체학회 : 저널
유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기